Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network( )

BACKGROUND: Tenofovir alafenamide (TAF), a prodrug of tenofovir (TFV), is included in the majority of the recommended first-line antiretroviral regimens for patients living with human immunodeficiency virus (HIV), but there are limited data on TAF use in pregnant women. We aimed to examine the plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukkems, Vera E, Necsoi, Coca, Hidalgo Tenorio, Carmen, Garcia, Coral, Alba Alejandre, Irene, Weiss, Fabian, Lambert, John S, van Hulzen, Astrid, Richel, Olivier, te Brake, Lindsey H M, van der Meulen, Eric, Burger, David, Konopnicki, Deborah, Colbers, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464066/
https://www.ncbi.nlm.nih.gov/pubmed/34864950
http://dx.doi.org/10.1093/cid/ciab1010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464066/
https://www.ncbi.nlm.nih.gov/pubmed/34864950
http://dx.doi.org/10.1093/cid/ciab1010

Ejemplares similares